Characterizing the role of mitochondrial DNA mutations on retinal degeneration
Active Project Grant Awarded Last action
- Award ID
- F31EY035133
- Recipient
-
Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University UEI M5QFLTCTSQN6
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $291,848
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date 90% complete
- Place of performance
- Cleveland, OH 44195, USA
Award details come from USAspending.gov.
Description
- Abstract
- Retinal cell health is a vital aspect of ophthalmic biology allowing US to see the world around US every day. Degeneration of the retina and/or retinal pigment epithelium (RPE) is a central cause of numerous clinical eye disorders such as age-related macular degeneration, retinitis pigmentosa, or glaucoma. Recent investigation into disease etiology has implicated oxidative stress and mitochondrial dysfunction as key players in the initiation of an unhealthy retina. More specifically, analysis of primary tissue from human donors have shown increases in mitochondrial DNA (MTDNA) mutations in these samples. This study uses novel pre-clinical models to test the hypothesis that impaired mitochondrial function due to MTDNA damage results in age-related retinal and RPE degeneration. To address this hypothesis we are utilizing polymerase gamma (POL ) as a tool to study the impact of MTDNA mutation burden on retinal health in both animal and cellular models. Previously developed mutated versions of POL have shown to drastically increase MTDNA mutation rate, rendering this an effective method to analyze the impact MTDNA mutations have on specific biological mechanisms. The goal of this proposal is to determine the contribution MTDNA damage has on the onset and progression of retinal degeneration. This study will pinpoint how mitochondrial dysfunction and oxidative stress driven by MTDNA mutations promote an unhealthy state of the retina. Successful completion of this study will not only offer deeper mechanistic understanding of retinal disease, but may also open a novel avenue for therapeutic targeting.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $564 | |
| Amendment | $48,974 | |
| Amendment | $48,974 | |
| Amendment | $1,280 | |
| Amendment | $1,280 | |
| Amendment | $47,694 | |
| Amendment | $47,694 | |
| Amendment | $0 | |
| Amendment | $47,694 | |
| Amendment | $0 | |
| Amendment | $47,694 | |
| Original award | $0 |
Show all 12
Quick answers
Who received award F31EY035133?
F31EY035133 was awarded to Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University by National Eye Institute (National Institutes of Health) on June 1, 2024.
How much is award F31EY035133 worth?
$291,848 has been obligated on F31EY035133.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award